Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × ponatinib × Clear all

NCT01838642 2017-02-15

Ponatinib for Advanced Medullary Thyroid Cancer

Phase 2 Terminated

3 enrolled 13 charts

Thyroid Neoplasms